Virtual Medicinal Product (VMP)
-
Rifaximin 200mg tablets
Name Details
Current Name
Rifaximin 200mg tablets
|
Start Date
06-11-2007
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A07AA11
BNF |
Current BNF
05010700
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010700
|
Start Date
25-05-2012
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41954911000001108 |
09-06-2023 |
|
412555008 |
08-11-2007 |
08-06-2023 |
VMP Ingredients
VMP ingredients table
Rifaximin |
Based on Ingredient Substance |
|
200 mg |
|
Name
Rifaximin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
200
Strength and UOM (Dmr)
Parent Products
-
VTM
Rifaximin
-
VMP
(Current) Rifaximin 200mg tablets
Virtual Medicinal Product Pack (VMPP) Information